Skip to content

Clinical trials

Active, not recruiting Phase 1/2 trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Status: Active, not recruiting Country / region: New Zealand Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20171
20191
20204
20211
20222
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche4
Merck Sharp & Dohme LLC2
Dynavax Technologies Corporation1
Dyne Therapeutics1
Epicrispr Biotechnologies, Inc.1
Geneos Therapeutics1
Immunocore Ltd1
Intellia Therapeutics1
MedImmune LLC1
Monash Medical Centre1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Non-Hodgkin2
Angioedemas, Hereditary1
Brain Neoplasms1
Bronchopulmonary Dysplasia1
Gastrointestinal Neoplasms1
Herpes Zoster1
Inflammation1
Muscular Dystrophies1
Muscular Dystrophy, Facioscapulohumeral1
Myotonic Dystrophy1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.